Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Biotin supplements did not significantly reduce hair loss in rats on valproic acid.

Cord blood platelet-rich plasma may safely improve vulvar lichen sclerosus symptoms.

The combination treatment showed a higher response rate but no significant survival benefits.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Avacopan may cause unexpected side effects, so early monitoring is important.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Entospletinib effectively prevents eye and skin GVHD in mice.

Vorasidenib can cause unusual hair growth.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Newly made nicotinamide compounds could potentially treat cancer.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

Butin is effective in treating vitiligo in mice.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Nilotinib can cause generalized keratosis pilaris.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A woman's hair turned white after taking a cancer drug called dasatinib.